Notice of Intent to Extend - Infectious Disease Testing
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
|---|---|
| State: | New York |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Aug 20, 2025 |
| Due Date: | Sep 3, 2025 |
| Solicitation No: | 36C24225Q1005 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Aug 20, 2025 05:18 pm EDT
- Original Response Date: Sep 03, 2025 10:00 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Sep 04, 2025
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
NY 12203USA
This is a notice of intent Pursuant to FAR 5.203(a) posting requirements, not a request for quotes.
The Department of Veterans Affairs (DVA) on behalf of Veterans Integrated Services Network (VISN) 02, Bronx and Northport VA Medical Centers, intends to extend testing supply services by issuing an extension to the incumbent, BioMerieux Inc.
Contractor: BioMerieux Inc.
Street Address: 515 S.Colorow Drive
City, State, Zip: Salt Lake City, UT 84108
The Department of Veterans Affairs (DVA), VISN 02, Bronx and Northport VA Medical Centers require an extension to ensure the continuity of essential infectious disease testing supply services impacting patient care.
The aforementioned contractor is currently performing under Blanket Purchase Agreement (BPA) 36C24224A0027 with the period of performance concluding on September 30, 2025. The anticipated period of performance for the extension is six (6) months, from October 1, 2025, through March 31, 2026.
This extension will provide the Department of Veterans Affairs (DVA) with additional time to adequately survey the current market; determining vendor capabilities and the potential for competition. This requirement has been submitted to be procured under FAR Part 8 procedures; an award action is anticipated to be awarded in December 2026.
This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time (Est) on September 3, 2025. Responses to be submitted to Lindsay Goldsmith, Contracting Officer at lindsay.goldsmith@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
- 113 HOLLAND AVE
- ALBANY , NY 12208
- USA
- Aug 20, 2025 05:18 pm EDTSpecial Notice (Original)
See Also
15 Title: Case Medical Rigid Sterilization Containers, Lids, Baskets. CR#: 2138673 Agency: State
The New York State Contract Reporter
Due by 9/24/2026
36 Title: SUNY Syracuse 2027 Series XXVII CR#: 2139128 Agency: State University of
The New York State Contract Reporter
Due by 10/14/2026
15 Title: SQUID Liquid Embolic Agent and related items manufactured by Balt USA
The New York State Contract Reporter
Due by 9/25/2026
05 Title: Lariat LAA Closure Device System CR#: 2136860 Agency: State University of
The New York State Contract Reporter